Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Comparison 63. SE ‐ Orthostatic symptoms.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Citalopram versus heterocyclics 1 96 Odds Ratio (M‐H, Random, 95% CI) 1.0 [0.19, 5.22]
1.1 versus Maprotiline 1 96 Odds Ratio (M‐H, Random, 95% CI) 1.0 [0.19, 5.22]
2 Citalopram versus newer ADs 1   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
2.1 versus Reboxetine 1 357 Odds Ratio (M‐H, Random, 95% CI) 0.44 [0.13, 1.47]